Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Blood
|
October 31, 2015
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Marie-Lorraine Chretien, Jill Corre, Valerie Lauwers-Cances, et al.
Blood Advances
|
September 18, 2025
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Sarah Cayla, Lionel Karlin, Jerome Lambert, et al.
Clinical Hematology International
|
June 1, 2026
Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France
Decaux Olivier, Ronan Garlantezec, Aurore Perrot, et al.
Blood
|
November 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort
Pierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel, et al.
Blood Advances
|
February 24, 2026
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Sarah Cayla, Lionel Karlin, Jérôme Lambert, et al.
Blood
|
January 11, 2015
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results
Xavier Leleu, Lionel Karlin, Margaret Macro, et al.
American Journal of Hematology
|
January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study
Charles Dumontet, Delphine Demangel, Perrine Galia, et al.
Blood
|
October 5, 2018
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, et al.
The Lancet. Oncology
|
October 2, 2025
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial
Salomon Manier, Jérôme Lambert, Cyrille Hulin, et al.
Blood
|
September 2, 2022
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
Stéphanie Guillet, Valentine Loustau, Emmanuelle Boutin, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Blood
|
October 31, 2015
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Marie-Lorraine Chretien, Jill Corre, Valerie Lauwers-Cances, et al.
Blood Advances
|
September 18, 2025
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Sarah Cayla, Lionel Karlin, Jerome Lambert, et al.
Clinical Hematology International
|
June 1, 2026
Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France
Decaux Olivier, Ronan Garlantezec, Aurore Perrot, et al.
Blood
|
November 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort
Pierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel, et al.
Blood Advances
|
February 24, 2026
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study
Sarah Cayla, Lionel Karlin, Jérôme Lambert, et al.
Blood
|
January 11, 2015
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results
Xavier Leleu, Lionel Karlin, Margaret Macro, et al.
American Journal of Hematology
|
January 2, 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study
Charles Dumontet, Delphine Demangel, Perrine Galia, et al.
Blood
|
October 5, 2018
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
Laurent Garderet, Frederique Kuhnowski, Benoit Berge, et al.
The Lancet. Oncology
|
October 2, 2025
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial
Salomon Manier, Jérôme Lambert, Cyrille Hulin, et al.
Blood
|
September 2, 2022
Immune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study
Stéphanie Guillet, Valentine Loustau, Emmanuelle Boutin, et al.
Page
of 11